Judy D. Olian United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Judy D. Olian is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 7,405 shares of UTHR, which is worth approximately $2.51 Million. The most recent transaction as insider was on Jul 13, 2024, when has been sold 1,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.41K
1.37% 3M change
10.3% 12M change
Total Value Held $2.51 Million

Judy D. Olian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 13 2024
BUY
Exercise of conversion of derivative security
-
1,800 Added 19.55%
7,405 Common Stock
Jun 17 2024
SELL
Open market or private sale
$502,231 $295.43 p/Share
1,700 Reduced 23.27%
5,605 Common Stock
May 03 2024
SELL
Open market or private sale
$2,587,799 $258.78 p/Share
10,000 Reduced 57.79%
7,305 Common Stock
May 03 2024
BUY
Exercise of conversion of derivative security
$1,754,300 $175.43 p/Share
10,000 Added 36.62%
17,305 Common Stock
Mar 12 2024
SELL
Open market or private sale
$1,240,150 $248.03 p/Share
5,000 Reduced 40.63%
7,305 Common Stock
Mar 12 2024
BUY
Exercise of conversion of derivative security
$877,150 $175.43 p/Share
5,000 Added 28.89%
12,305 Common Stock
Nov 29 2023
SELL
Bona fide gift
-
950 Reduced 11.51%
7,305 Common Stock
Jul 07 2023
BUY
Exercise of conversion of derivative security
-
1,750 Added 17.49%
8,255 Common Stock
Jan 03 2023
SELL
Open market or private sale
$317,699 $276.26 p/Share
1,150 Reduced 15.02%
6,505 Common Stock
Dec 09 2022
SELL
Open market or private sale
$284,820 $282.0 p/Share
1,010 Reduced 11.66%
7,655 Common Stock
Nov 08 2022
SELL
Open market or private sale
$159,053 $265.09 p/Share
600 Reduced 6.48%
8,665 Common Stock
Nov 07 2022
SELL
Bona fide gift
-
1,125 Reduced 10.83%
9,265 Common Stock
Jul 08 2022
BUY
Exercise of conversion of derivative security
-
2,160 Added 17.21%
10,390 Common Stock
Jun 27 2022
SELL
Open market or private sale
$2,406,400 $240.64 p/Share
10,000 Reduced 54.85%
8,230 Common Stock
Jun 27 2022
BUY
Exercise of conversion of derivative security
$1,754,300 $175.43 p/Share
10,000 Added 35.42%
18,230 Common Stock
May 26 2022
SELL
Open market or private sale
$2,264,600 $226.46 p/Share
10,000 Reduced 54.85%
8,230 Common Stock
May 26 2022
BUY
Exercise of conversion of derivative security
$1,754,300 $175.43 p/Share
10,000 Added 35.42%
18,230 Common Stock
Nov 23 2021
SELL
Bona fide gift
-
920 Reduced 10.05%
8,230 Common Stock
Jun 26 2021
BUY
Exercise of conversion of derivative security
-
3,360 Added 26.86%
9,150 Common Stock
Apr 01 2021
SELL
Open market or private sale
$778,127 $184.96 p/Share
4,207 Reduced 42.08%
5,790 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$321,247 $76.36 p/Share
4,207 Added 29.62%
9,997 Common Stock
Mar 17 2021
SELL
Open market or private sale
$357,510 $170.0 p/Share
2,103 Reduced 26.64%
5,790 Common Stock
Mar 17 2021
BUY
Exercise of conversion of derivative security
$160,585 $76.36 p/Share
2,103 Added 21.04%
7,893 Common Stock

Also insider at

ARES
Ares Management Corp Financial Services
Director
MAT
MATTEL INC Consumer Cyclical
Director
JDO

Judy D. Olian

Los Angeles, CA

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR